4//SEC Filing
Murugan Amar 4
Accession 0000905148-24-002304
CIK 0001604464other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 6:27 PM ET
Size
8.2 KB
Accession
0000905148-24-002304
Insider Transaction Report
Form 4
Murugan Amar
SVP, GC & Secretary
Transactions
- Sale
Common Stock
2024-08-16$6.63/sh−877$5,814→ 27,108 total - Sale
Common Stock
2024-08-16$6.63/sh−192$1,273→ 26,916 total - Sale
Common Stock
2024-08-16$6.63/sh−89$590→ 26,827 total
Footnotes (3)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
- [F3]This amount includes 4,507 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2024, and reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001809916
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 6:27 PM ET
- Size
- 8.2 KB